POST-COVID-19 PHARMA IN JAPAN CRITICAL AREAS OF TRANSFORMATION TO CONSIDER

-

eBook #1 in a series of 3

A SEISMIC SHIFT IN A GO-TO-MARKET STRATEGY

 

Top pharmaceutical companies in Japan face three critical challenges to transformation, that when addressed increase the potential for success:

 

 

1.Access to and focus on the physician is not what it was. So what now?

 

2.Will your brand strategy, for & beyond the physician, keep pace in this new post-COVID-19 era?

 

3.How are you transforming your sales teams to deliver value to healthcare stakeholders?

 

 

Most of these challenges have already been present even before but evolving slowly.

 

Now with this new era brought on by COVID-19 and the restrictions placed during this period are highlighting and focusing on the already existing pain points, accelerating them, and adding up other challenges.

 

Find out more about these key trends in our eBook below available in English and Japanese. 

 

Click on any of the images below to download the version you prefer:

 

 

PH in Japan ebook EN   PH in Japan ebook JP

 

 

Recent Posts

Related Blogs